Active Pharmaceutical Ingredient (API) Market worth $ 281.90 Billion, Globally, by 2028 at 5.65 % CAGR: Verified Market Research™

JERSEY CITY, N.J., May 31, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Active Pharmaceutical Ingredient (API) Market" By Molecule (Small Molecule and Large Molecule), By Application (Pain management, Respiratory Diseases, Diabetes & Others), By Type (Innovative APIs and Generic APIs), By Type of manufacturer (Captive Manufacturers and Merchant Manufacturers), By Type of Drug (Prescription Drugs and Over the Counter Drugs), and By Geography. According to Verified Market Research, the Global Active Pharmaceutical Ingredient (API) Market was valued at USD 181.68 Billion in 2020 and is projected to reach USD 281.90 Billion by 2028, growing at a CAGR of 5.65% from 2021 to 2028.

Verified Market Research Logo

Download PDF Brochure:

Browse in-depth TOC on "Active Pharmaceutical Ingredient (API) Market"

202 - Pages
126 – Tables
37 – Figures

Global Active Pharmaceutical Ingredient (API) Market Overview

An important driver for growth of the Global Active Pharmaceutical Ingredient (API) market is the rise in the incidences of chronic diseases. Certain key facts from the WHO state that, "CVDs (Cardiovascular Diseases) are the number 1 cause of death globally: more people die annually from CVDs than from any other cause. An estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. Of these deaths, 85% are due to heart attack and stroke." 10 million deaths were caused by cancer in 2020, whereas Asthma, the most common chronic disease found in children was responsible for 461000 deaths in 2019.

The increasing number of these diseases calls for a variety of drugs of treat them, which in turn is responsible for the expanding of Global Active Pharmaceutical Market. Another important growth driver is the rise in geriatric population around the world. According to the United Nations there were 703 million people aged 65 and above worldwide in 2019. Such a high number of geriatric population gives way for contracting a lot of chronic and acute diseases which would require newer drugs to mitigate their effects, thus leading to a rise in the Global Active Pharmaceutical Ingredient (API) Market.

Key Developments in Active Pharmaceutical Ingredient (API) Market

  • Pfizer (US) signed a multi-year agreement with Gilead Sciences to manufacture and supply Gilead's antiviral drug (Remdesivir) for the treatment of COVID-19 in 2020.
  • Novartis acquired, and agreed to enter in a manufacturing and supply agreement with Aspen's Japanese operations to consolidate its position in the global generics and off-patent medicines market in 2020.
  • Boehringer Ingelheim , to widen its oncology product portfolio, acquired Northern Biologics, which focuses on therapeutic antibodies targeting the tumor microenvironment in April 2020.

The major players in the market are Aurobindo Pharma Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Boehringer Ingelheim International GmbH, Cipla, Inc., Merck & Co., Inc., AbbVie, Inc., among others.

Verified Market Research has segmented the Global Active Pharmaceutical Ingredient (API) Market On the basis of Molecule, Application, Type, Type of manufacturer and Type of Drug and Geography.

  • Active Pharmaceutical Ingredient (API) Market by Molecule
    • Small Molecule
    • Large Molecule
  • Active Pharmaceutical Ingredient (API) Market by Application
    • Pain management
    • Respiratory Diseases
    • Diabetes
    • Cardiovascular Disease
    • Communicable Diseases
    • Oncology
    • Other Therapeutic Applications (Orthopedics, Urology and Nephrology, Ophthalmology, Pulmonology, Women's Health, and Gastroenterology)
  • Active Pharmaceutical Ingredient (API) Market by Type
    • Innovative APIs
    • Generic APIs
  • Active Pharmaceutical Ingredient (API) Market by Type of Manufacturers
    • Captive Manufacturers
    • Merchant Manufacturers
  • Active Pharmaceutical Ingredient (API) Market by Type of Drug
    • Prescription Drugs
    • Over the Counter Drugs
  • Active Pharmaceutical Ingredient (API) Market by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

High Potency Active Pharmaceutical Ingredient (HPAPI) Market by Type (Innovative HPAPI And Generic HPAPI), by Type of Manufacturer (Captive HPAPI Manufacturers and Merchant HPAPI Manufacturers), by Type of Synthesis (Synthetic HPAPI Market and Biotech HPAPI Market), by Therapeutic Application (Oncology, Hormonal Disorders, Glaucoma, and Other Therapeutic. Applications), by Geography, Forecast, 2020-2027

Duloxetine Active Pharmaceutical Ingredients (API) Market by Product Type (Major Depression Drug, Generalized Anxiety Disorder Drug, Fibromyalgia Drugs, Neuropathic Pain Medication, Other), by Application (Pharmaceutical and Biotechnology Industries, Hospital, Other), by Geography, Forecast, 2020-2027

Animal Health Active Pharmaceutical Ingredients Market by Product (Antiparasitics, Anti-infectives, NSAIDs & Anesthetics, and Others), by Application (Pharmacy, Pet Hospital, and Others), by Geography, Forecast, 2020-2027

Pharmaceuticals Market by Formulation (tablets, capsules, injectables, sprays, suspensions, powders, and other formulations), by Route of Administration (Oral Drugs, Parenteral Drugs, Topical Drugs, Novel Drugs, Oncological Drugs, and Others), by Drug Type (Branded Drugs, Generic Drugs, Biological Drugs, Others), by Geography, Forecast, 2020-2027

Top 10 pharmaceutical packaging companies: Salvation of global medical industry

Visualize Active Pharmaceutical Ingredient (API) Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes 
Verified Market Research 
US: +1 (650)-781-4080 
UK: +44 (753)-715-0008 
APAC: +61 (488)-85-9400  
US Toll Free: 1 (800)-782-1768  
Follow Us: LinkedIn | Twitter


Cision View original content:

SOURCE Verified Market Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.